View : 141 Download: 36

Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: A post hoc analysis of the GOAL study

Title
Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: A post hoc analysis of the GOAL study
Authors
Bousquet J.Barnes N.Gibbs M.Gul N.Tomkins S.A.Zhou X.Cho Y.-J.Park H.-S.Busse W.Zhong N.
Ewha Authors
조영주
SCOPUS Author ID
조영주scopus
Issue Date
2017
Journal Title
BMC Pulmonary Medicine
ISSN
1471-2466JCR Link
Citation
BMC Pulmonary Medicine vol. 17, no. 1
Keywords
Asian patientsAsthmaAsthma controlAsthma treatmentFluticasone propionate/salmeterolICS/LABA treatment
Publisher
BioMed Central Ltd.
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
Background: To analyse the efficacy of fluticasone propionate (FP) alone and combined with salmeterol (SAL) in achieving guideline-defined asthma control in Asian patients. Methods: A post hoc analysis of the GOAL study in which patients were stratified by prior-medication use into inhaled corticosteroid (ICS)-naïve (Stratum [S] 1), low-dose ICS (S2), and medium-dose ICS (S3), and randomised to receive FP/SAL or FP. Doses were stepped-up every 12 weeks until Totally Controlled asthma or maximum dose was reached (PhI) and then maintained until study end (PhII). The primary endpoint was the proportion of patients achieving Well-Controlled asthma during PhI. Additional endpoints included Total Control and adverse events. Asian and non-Asian patients were analysed separately. Results: In Asian patients in PhI, 74% (n = 87/118) in S1 achieved Well-Controlled asthma with FP/SAL versus 74% (n = 89/121) with FP alone (p = 0.839); corresponding values were 76% (n = 81/107) versus 60% (n = 62/104; p = 0.005) in S2, and 58% (n = 59/102) versus 43% (n = 41/95; p = 0.015) in S3. More patients in all three strata achieved Totally Controlled asthma with FP/SAL versus FP alone. Control was achieved more rapidly and with lower ICS doses with FP/SAL versus FP. A high proportion of patients who achieved control during PhI maintained control during PhII. Similar trends were found in non-Asian patients. No new safety concerns were identified. Conclusions: A greater proportion of Asian patients (S2 and S3, for Well-Controlled; all strata, for Totally Controlled) achieved guideline-defined asthma control with FP/SAL versus FP alone. High proportions of Asian patients in S1 achieved Well-Controlled asthma in both treatment groups. © 2017 The Author(s).
DOI
10.1186/s12890-017-0410-x
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
Asthma control.pdf(1.67 MB) Download
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE